Coronary Microvascular Disease
42
12
16
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
4.8%
2 terminated out of 42 trials
85.7%
-0.8% vs benchmark
10%
4 trials in Phase 3/4
8%
1 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (42)
A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
Coronary Flow During Rapid Heart Rates
Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry)
Exercise and Coronary Microvascular Disease
The Euro-CRAFT Registry
Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)
Coronary Sinus Reducer in Coronary Microvascular Disease
A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
Barts-MINOCA Registry
Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)
A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)
An Observational Study of Coronary Microvascular Disease of China
A Clinical Study of Fundus OCTA for the Identification of CMD
Serial PET MPI in Patients Undergoing Cancer Treatment
MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)
A Non-invasive Index of Microciculatory Resistance
Clinical Evaluation of Aromatic Wentong in the Treatment of Coronary Microvascular Disease
Impact of Exercise Training on Ischemia With Non-Obstructive Coronary Arteries (INOCA): The ExINOCA Study
Qishenyiqi Dripping Pill for Coronary Microvascular Disease
Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition